During the past decade, Delaware Valley Retina Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Delaware Valley Retina Associates" #1 sponsor was "Jaeb Center for Health Research" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Genaera Corporation" with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Delaware Valley Retina Associates" #1 collaborator was "National Eye Institute (NEI)" with 4 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "MEDARVA Foundation" with 1 trials as a collaborator, "Milton S. Hershey Medical Center" with 1 trials as a collaborator and "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Delaware Valley Retina Associates" are "Geographic Atrophy" (3 trials), "Diabetic Macular Edema" (2 trials), "Macular Degeneration" (2 trials), ""Wet" Age-Related Macular Degeneration" (1 trials) and "Age Related Macular Degeneration" (1 trials). Many other conditions were trialed in "Delaware Valley Retina Associates" in a lesser frequency.

Most popular intervention types in "Delaware Valley Retina Associates" are "Drug" (10 trials), "Other" (2 trials), "Procedure" (2 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lampalizumab" (2 trials), "Ranibizumab" (2 trials), "1mg triamcinolone acetonide" (1 trials), "4mg triamcinolone acetonide" (1 trials) and "Abicipar Pegol" (1 trials). Other intervention names were less common.

The vast majority of trials in "Delaware Valley Retina Associates" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Delaware Valley Retina Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Delaware Valley Retina Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Delaware Valley Retina Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".